# Progress Note 04 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: John Locke (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN001-SYN-TD
- Date: 1692-09-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Prudence Hartwell-Osei, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: Periodic preventive medicine visit, established patient, age 40 to 64, with voluntary advance care planning

## Chief complaint

Preventive health visit at 60. **S**

## History of present illness

Mr. Locke returns for his preventive visit, having turned 60 last week. He completed the health risk questionnaire beforehand. His asthma has been steady in the three months since tiotropium was added: he uses one or two extra inhalations of budesonide-formoterol a week, sleeps through the night, and has had no flare. The dose counters show no missed maintenance doses. He finished pulmonary rehabilitation in the spring and keeps up the walking program five days a week. The open fires in his rooms have stayed out of use, and the HEPA air cleaner runs in his study and bedroom. He spent four days in the city last month, checked the air quality index each morning, and needed his reliever twice. He has had no fever, weight loss, night sweats, or blood in his sputum. He had a normal colonoscopy eight years ago. **S**

| Element | Detail |
|---|---|
| Visit | Preventive health visit, age 60 |
| Active conditions | Asthma with persistent airflow limitation on budesonide-formoterol maintenance and reliever with add-on tiotropium; exposure to air pollution |
| Medicines | Budesonide-formoterol 160/4.5 mcg two inhalations twice daily plus as needed; tiotropium 2.5 mcg two inhalations daily |
| Screening history | Normal colonoscopy eight years ago; HIV, hepatitis B, and hepatitis C tests negative in his fifties |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, better than for many years |
| Psychosocial | Lives with long-standing friends; busy with writing and his board work; no financial worries |
| Behavioral | Never smoker; wine a few evenings a week (AUDIT-C 2); walks 30 to 40 minutes five days a week; plain diet with fruit and vegetables most days |
| Environmental | No open fires in his rooms; HEPA air cleaner in study and bedroom; checks the air quality index before city trips |
| Activities of daily living | Independent |
| Home safety | Smoke and carbon monoxide alarms fitted; no firearms |
| Sexual health | Not sexually active; no risk factors for sexually transmitted infection |
| Hearing and vision | No hearing difficulty; reading glasses; eye examination last year |
| Sleep | Sleeps through the night; no snoring reported |
| Pain | None |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight 63.0 kg, up 1 kg since spring; no fever or night sweats |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No hoarseness, sore mouth, or thrush on inhaled corticosteroid; no nasal blockage |
| Cardiovascular | Negative | No chest pain, palpitations, ankle swelling, or breathlessness lying flat |
| Respiratory | Positive | Mild breathlessness on hills; occasional cough after city days; no wheeze at rest; no hemoptysis |
| Gastrointestinal | Negative | No heartburn, bleeding, or change in bowel habit |
| Genitourinary | Negative | No urinary hesitancy or retention on tiotropium; no nocturia |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No rash or easy bruising |
| Neurological | Negative | No headache, numbness, or weakness |
| Psychiatric | Negative | Mood good; PHQ-2 0 |

11 systems reviewed. **S**

## Current medications

- Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 4): two inhalations twice daily and one inhalation as needed for symptoms, no more than 12 inhalations a day **S**
- Tiotropium 2.5 mcg/actuation soft-mist inhaler, two inhalations once daily (add-on long-acting muscarinic antagonist, GINA step 5) **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/74 mmHg; pulse 74 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 63 kg; BMI 19.9 kg/m². All vital signs are synthetic.

PHQ-2: 0; Total cholesterol: 182 mg/dL; HDL cholesterol: 64 mg/dL; LDL cholesterol: 101 mg/dL; Triglycerides: 85 mg/dL. All results are synthetic.

## Change since baseline

- PHQ-2: 1 at baseline, 0 at this visit **S**

## Immunizations given today

- Influenza vaccine, 1692-1693 season **S**
- COVID-19 mRNA vaccine, this season's formula **S**
- Respiratory syncytial virus vaccine, single dose **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Thin, well; BMI 19.9 |
| Mouth | No oral candidiasis |
| Cardiovascular | Regular rhythm; no murmur; no edema; blood pressure 120/74 mmHg |
| Respiratory | Good air entry; faint end-expiratory wheeze on forced expiration only; oxygen saturation 97 percent |
| Abdomen | Soft, non-tender; no masses |
| Skin | No bruising or thinning |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Preventive health visit completed**. Health risk assessment reviewed and a personalized prevention plan made. His chief risk is his chronic airway disease, now well managed, which makes the seasonal respiratory vaccines a priority. Lipids are normal and his estimated 10-year cardiovascular risk is below 7.5 percent. **S**
   - Next preventive visit in one year.
2. **Asthma with persistent airflow limitation** (J45.40). Steady three months after adding tiotropium: reliever once or twice a week, no night symptoms, no flare; no inhaled-corticosteroid side effects. **S**
   - Continue budesonide-formoterol and tiotropium.
   - Asthma review with an Asthma Control Test as booked next month.
   - Influenza, COVID-19, and RSV vaccines today.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, this season | Completed today | Given today |
| COVID-19 vaccine, this season | Completed today | Given today |
| RSV vaccine | Completed today | Single dose given today; recommended at 60 to 74 with chronic lung disease |
| Recombinant zoster vaccine | Due | Recommended from 50; he preferred not to have a fourth injection today and will have dose 1 at his next visit |
| Pneumococcal conjugate vaccine | Up to date | PCV20 given six months ago |
| Tetanus booster | Up to date | Tdap five years ago |
| Colorectal cancer screening | Up to date | Normal colonoscopy eight years ago; next due in two years |
| Depression screening | Completed today | PHQ-2 0 |
| Lipid screening and cardiovascular risk | Completed today | Total cholesterol 182 mg/dL, HDL 64 mg/dL, LDL 101 mg/dL, triglycerides 85 mg/dL; blood pressure 120/74 mmHg; never smoker; no diabetes; estimated 10-year risk below 7.5 percent, so no statin |
| Diabetes screening | Not indicated | BMI 19.9 with no other risk factors |
| HIV, hepatitis B, and hepatitis C screening | Up to date | One-time tests negative in his fifties |
| Alcohol misuse screening | Completed today | AUDIT-C 2 |
| Prostate cancer screening | Declined | Shared decision about PSA screening at 55 to 69 discussed; he chose not to be screened this year |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never smoker; CT this spring showed no nodules |
| Hearing and vision | Up to date | No concerns; eye examination last year |

## Advance care planning

Voluntary advance care planning discussion of about 17 minutes, with his consent. He has not written a directive before. He names a long-standing friend in the household where he lives as his health care agent and took the state form to complete. He would want full treatment for any illness he might recover from, including a period on a ventilator for a severe asthma attack, and would not want his life prolonged by machines if he could not recover awareness. He asked that his health information be shared with his care team and his agent. **S**

## Guideline basis

- Global Strategy for Asthma Management and Prevention, 2025 update (2025), Global Initiative for Asthma
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- Colorectal Cancer: Screening (2021), U.S. Preventive Services Task Force
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022), U.S. Preventive Services Task Force
- Prostate Cancer: Screening (2018), U.S. Preventive Services Task Force
- Lung Cancer: Screening (2021), U.S. Preventive Services Task Force

## Follow-up

- Asthma review next month as booked; zoster vaccine dose 1 then. **S**
- Next scheduled visit 1692-10-22: asthma review two weeks after a cold with a yellow-zone flare. **S**
